Monday, February 3, 2014
Session 1: Coronary
Chronic Stable Angina-QOL vs. MACE Reduction Benefit with Intervention
Speaker: Peter Wijngaard
Moderator: Steve Bailey
Panelists: Larry Dean, George Hanzel, Tarek Helmy, Bonnie Weiner
Session 1: Coronary
Coronary Lesion Assessment: Are FFR and iFR it?
Speaker: Tarek Helmy
Moderator: Steve Bailey
Panelists: Larry Dean, George Hanzel, Bonnie Weiner, Peter Wijngaard
Session 1: Coronary
Can OCT Identify ACS Patients Who Don't Need Stents?
Speaker: George Hanzel
Moderator: Steve Bailey
Panelists: Larry Dean, Tarek Helmy, Bonnie Weiner, Peter Wijngaard
Session 2: Structural
Is Perivalvular Leak the Achilles Heel of TAVR and How to Obtain Best Outcomes
Speaker: Larry Dean
Moderator: Jim Zidar
Panelists: Steve Bailey, Robert Bersin, Bill O’Neill
Session 2: Structural
Valves and Other Devices for Structural Mitral Valve Disease
Speaker: Bill O’Neill
Moderator: Jim Zidar
Panelists: Steve Bailey, Robert Bersin, Larry Dean
Session 2: Structural
Devices for Functional MR: One Clip, Two Clip, Three Clip, Four?
Speaker: Steve Bailey
Moderator: Jim Zidar
Panelists: Robert Bersin, Larry Dean, Bill O’Neill
Session 3: Endovascular
Aortic Frontiers: The Prophylactic Treatment of Uncomplicated Type B Dissection
Speaker: Robert Bersin
Moderator: Tyrone Collins
Panelists: Dieter Liermann, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek, Jim Zidar
Session 3: Endovascular
Endovascular Drug Eluting Balloons vs. Stents: Is Provisional Stenting Back?
Speaker: Jim Zidar
Moderator: Tyrone Collins
Panelists: Robert Bersin, Dieter Liermann, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek
Session 3: Endovascular
What to do with the Asymptomatic Carotid Stenosis?
Speaker: Klaus Mathias
Moderator: Tyrone Collins
Panelists: Robert Bersin, Dieter Liermann, Sigrid Nikol, Souheil Saddekni, Jiri Vitek, Jim Zidar
Tuesday, February 4, 2014
Session 4: Emerging Therapies
Destination Therapy for Heart Failure: What to do When the Batteries Run Out?
Speaker: Michael Mooney
Moderator: Nickolas Kipshidze
Panelists: George Hanzel, David Kallend, Bill O’Neill, Peter Wijngaard
Session 4: Emerging Therapies
Myocyte Recovery Strategies and Cell Therapies for Myocardial Regeneration Post MI
Speaker: Bill O’Neill
Moderator: Nickolas Kipshidze
Panelists: George Hanzel, David Kallend, Michael Mooney, Peter Wijngaard
Session 4: Emerging Therapies
Novel Therapies for Plaque Inflammation
Speaker: David Kallend
Moderator: Nickolas Kipshidze
Panelists: George Hanzel, Michael Mooney, Bill O’Neill, Peter Wijngaard
Session 5: Coronary
CTOs: Should the Appropriateness Criteria Change in an Era of Better Outcomes?
Speaker: Bonnie Weiner
Moderator: Peter Wijngaard
Panelists: Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Kirk Garratt, Adam Greenbaum, Tarek Helmy, Michael Mooney
Session 5: Coronary
Transradial Access for STEMI: Is the ESC Consensus Recommendation Warranted by the Evidence?
Speaker: Kirk Garratt
Moderator: Peter Wijngaard
Panelists: Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Adam Greenbaum, Tarek Helmy, Michael Mooney, Bonnie Weiner
Session 5: Coronary
Outpatient Intervention: Good or Bad Dream?
Speaker: Adam Greenbaum
Moderator: Peter Wijngaard
Panelists: Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Kirk Garratt, Tarek Helmy, Michael Mooney, Bonnie Weiner
Session 6: Structural
PFO: Should Anyone be Closed and With What?
Speaker: Kirk Garratt
Moderator: Steve Bailey
Panelists: Gyula Gal, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu
Session 6: Structural
NEW TOPIC: Penumbra Direct Aspiration System: Removing Clots for Acute Ischemic Stroke
Speaker: Gyula Gal
Moderator: Steve Bailey
Panelists: Kirk Garratt, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu
Session 6: Structural
Hybrid Imaging: Synergy and Co-registration of X-ray, CT and 3D Echo in the Interventional Suite
Speaker: Brian O’Murchu
Moderator: Steve Bailey
Panelists: Gyula Gal, Kirk Garratt, Adam Greenbaum, Nickolas Kipshidze
Wednesday, February 5, 2014
Session 7: Endovascular
Mechanical Devices for Acute Stroke Intervention: Why Did the Trials Fail?
Speaker: Tyrone Collins
Moderator: Dieter Liermann
Panelists: Robert Bersin, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek
Session 7: Endovascular
DVT/PE: Why are Interventional Therapies so Far Behind the Times?
Speaker: Jiri Vitek
Moderator: Dieter Liermann
Panelists: Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni
Session 7: Endovascular
Novel Lower Extremity Interventions: Chocolate TOBA, or Something Like That?
Speaker: Sigrid Nikol
Moderator: Dieter Liermann
Panelists: Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Souheil Saddekni, Jiri Vitek
Session 8: Medical Therapies
HDL Raising: Raising the Dead?
Speaker: Dennis Goodman
Moderator: Bonnie Weiner
Panelists: Kirk Garratt, Richard Shaw, Peter Wijngaard
Session 8: Medical Therapies
CANCELLED - RNA Interference Therapies, Micro-RNA and Epigenetics
Speaker: Tim Henry
Moderator: Bonnie Weiner
Panelists: Kirk Garratt, Dennis Goodman, Richard Shaw, Peter Wijngaard
Session 8: Medical Therapies
Gene Mapping and Targeted Medical Therapies: The Next iPhone App?
Speaker: Richard Shaw
Moderator: Bonnie Weiner
Panelists: Kirk Garratt, Dennis Goodman, Peter Wijngaard
Session 9: Emerging Therapies
Renal Denervation: Is a BP Endpoint Sufficient or is a Reduction in MACE Necessary for Adoption and Reimbursement?
Speaker: Jeff Marshall
Moderator: Dennis Goodman
Panelists: Dieter Liermann, Klaus Mathias, B. O’Murchu, Souheil Saddekni, R. Shaw, Jim Zidar
Session 9: Emerging Therapies
Other Denervation Therapies: Hype or Substance?
Speaker: Klaus Mathias
Moderator: Dennis Goodman
Panelists: Dieter Liermann, Jeff Marshall, Brian O’Murchu, Souheil Saddekni, Richard Shaw, Jim Zidar
Session 9: Emerging Therapies
Devices for Diastolic Dysfunction: The Golden Parachute?
Speaker: Brian O’Murchu
Moderator: Dennis Goodman
Panelists: Dieter Liermann, Jeff Marshall, Klaus Mathias, Souheil Saddekni, R Shaw, Jim Zidar
Thursday, February 6, 2014
Session 10: Coronary
Is Intervention Dead in Diabetics with Multivessel Disease?
Speaker: Adam Greenbaum
Moderator: Michael Mooney
Panelists: George Hanzel, Tarek Helmy, Nickolas Kipshidze, Bill O’Neill, Richard Shaw
Session 10: Coronary
Bioresorbable Stents and Drug Eluting Balloons: How Do We Best Get the Drug There?
Speaker: Nickolas Kipshidze
Moderator: Michael Mooney
Panelists: Adam Greenbaum, George Hanzel, Tarek Helmy, Bill O’Neill, Richard Shaw
Session 10: Coronary
Best Approaches to Hemodynamic Support for Cardiogenic Shock and High Risk PCI
Speaker: Bill O’Neill
Moderator: Michael Mooney
Panelists: Adam Greenbaum, George Hanzel, Tarek Helmy, Nickolas Kipshidze, Richard Shaw
Session 11: Industry
How to Approach the Increasing Worldwide Disconnect Between Evidence, Indication and Reimbursement
Speaker: Roundtable Discussion
Moderator: Jeff Marshall
Panelists: Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw, Jason Struck, Mike Vonesh
Session 11: Industry
Cost Effectiveness Research: Sorely Needed for Interventional Therapies
Speaker: Roundtable Discussion
Moderator: Jeff Marshall
Panelists: Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw, Jason Struck, Mike Vonesh
Session 11: Industry
ACOs: Industry's Role in Bringing Providers and Payors Together
Speaker: Roundtable Discussion
Moderator: Jeff Marshall
Panelists: Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw, Jason Struck, Mike Vonesh
Session 12: IAGS Business Meeting